文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications.

作者信息

Karunakaran Bharathi, Gupta Raghav, Patel Pranav, Salave Sagar, Sharma Amit, Desai Dhruv, Benival Derajram, Kommineni Nagavendra

机构信息

National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, India.

School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

出版信息

Vaccines (Basel). 2023 Mar 15;11(3):661. doi: 10.3390/vaccines11030661.


DOI:10.3390/vaccines11030661
PMID:36992244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10051624/
Abstract

Lipid-based vaccine delivery systems such as the conventional liposomes, virosomes, bilosomes, vesosomes, pH-fusogenic liposomes, transferosomes, immuno-liposomes, ethosomes, and lipid nanoparticles have gained a remarkable interest in vaccine delivery due to their ability to render antigens in vesicular structures, that in turn prevents its enzymatic degradation in vivo. The particulate form of lipid-based nanocarriers confers immunostimulatory potential, making them ideal antigen carriers. Facilitation in the uptake of antigen-loaded nanocarriers, by the antigen-presenting cells and its subsequent presentation through the major histocompatibility complex molecules, leads to the activation of a cascade of immune responses. Further, such nanocarriers can be tailored to achieve the desired characteristics such as charge, size, size distribution, entrapment, and site-specificity through modifications in the composition of lipids and the selection of the appropriate method of preparation. This ultimately adds to its versatility as an effective vaccine delivery carrier. The current review focuses on the various lipid-based carriers that have been investigated to date as potential vaccine delivery systems, the factors that affect their efficacy, and their various methods of preparation. The emerging trends in lipid-based mRNA vaccines and lipid-based DNA vaccines have also been summarized.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/8ed279a24e4a/vaccines-11-00661-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/d1cee32a33f8/vaccines-11-00661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/d01e0e0f41aa/vaccines-11-00661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/2cb4aa6e3056/vaccines-11-00661-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/024c0fe4ee38/vaccines-11-00661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/dfd3fb400db2/vaccines-11-00661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/c523e34cc23e/vaccines-11-00661-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/a6790b28bdc8/vaccines-11-00661-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/6c53da5fae7d/vaccines-11-00661-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/293b152c5005/vaccines-11-00661-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/8ed279a24e4a/vaccines-11-00661-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/d1cee32a33f8/vaccines-11-00661-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/d01e0e0f41aa/vaccines-11-00661-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/2cb4aa6e3056/vaccines-11-00661-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/024c0fe4ee38/vaccines-11-00661-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/dfd3fb400db2/vaccines-11-00661-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/c523e34cc23e/vaccines-11-00661-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/a6790b28bdc8/vaccines-11-00661-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/6c53da5fae7d/vaccines-11-00661-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/293b152c5005/vaccines-11-00661-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b19/10051624/8ed279a24e4a/vaccines-11-00661-g010.jpg

相似文献

[1]
Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications.

Vaccines (Basel). 2023-3-15

[2]
Liposomes as vaccine delivery systems: a review of the recent advances.

Ther Adv Vaccines. 2014-11

[3]
Micro/nanoparticle adjuvants for antileishmanial vaccines: present and future trends.

Vaccine. 2012-12-7

[4]
Vaccine approaches for antigen capture by liposomes.

Expert Rev Vaccines. 2023

[5]
Applications of Lipid-based Nanocarriers for Parenteral Drug Delivery.

Curr Med Chem. 2022

[6]
Gel Phase 1,2-Distearoyl--glycero-3-phosphocholine-Based Liposomes Are Superior to Fluid Phase Liposomes at Augmenting Both Antigen Presentation on Major Histocompatibility Complex Class II and Costimulatory Molecule Display by Dendritic Cells .

ACS Infect Dis. 2019-11-8

[7]
Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response.

Nanomedicine. 2009-5-14

[8]
Design and Preparation of Solid Lipid Nanoparticle (SLN)-Mediated DNA Vaccines.

Methods Mol Biol. 2022

[9]
Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines.

Mol Biotechnol. 2023-5

[10]
Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.

Biomaterials. 2014-6-23

引用本文的文献

[1]
Emerging Biomimetic Drug Delivery Nanoparticles Inspired by Extracellular Vesicles.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025

[2]
The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery.

Molecules. 2025-3-6

[3]
Breaking barriers: Smart vaccine platforms for cancer immunomodulation.

Cancer Commun (Lond). 2025-5

[4]
Research progress of mosquito-borne virus mRNA vaccines.

Mol Ther Methods Clin Dev. 2024-12-12

[5]
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant.

J Med Chem. 2024-12-26

[6]
Local and systemic humoral immune responses to Histophilus somni recombinant antigens administered intranasally and subcutaneously to dairy calves.

Sci Rep. 2024-11-11

[7]
Achieving Endo/Lysosomal Escape Using Smart Nanosystems for Efficient Cellular Delivery.

Molecules. 2024-7-1

[8]
Nanotechnology Integrated Innovative Drug Delivery and Therapy for Cancer.

Curr Pharm Biotechnol. 2024-4-22

[9]
Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy.

Int J Nanomedicine. 2024

[10]
Solid Lipid Nanoparticles as an Innovative Lipidic Drug Delivery System.

Pharm Nanotechnol. 2025

本文引用的文献

[1]
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery.

Pharmaceutics. 2023-1-6

[2]
Cationic lipid potentiated the adjuvanticity of polysaccharide derivative-modified liposome vaccines.

J Control Release. 2023-10

[3]
Ethosome as antigen delivery carrier: optimisation, evaluation and induction of immunological response via nasal route against hepatitis B.

J Microencapsul. 2022-6

[4]
Development of (Inhalable) Dry Powder Formulations of AS01-Containing Vaccines Using Thin-Film Freeze-Drying.

Int J Pharm. 2022-6-25

[5]
Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application.

Pharmaceutics. 2022-2-28

[6]
A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery.

Mol Ther Methods Clin Dev. 2022-6-9

[7]
Efficacy of immunization with a recombinant S. aureus vaccine formulated with liposomes and ODN-CpG against natural S. aureus intramammary infections in heifers and cows.

Res Vet Sci. 2022-7

[8]
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.

Molecules. 2022-2-17

[9]
Liposomes as Adjuvants and Vaccine Delivery Systems.

Biochem (Mosc) Suppl Ser A Membr Cell Biol. 2022

[10]
Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.

J Control Release. 2022-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索